Cargando…
Artificial Neural Networks (ANN) for the Simultaneous Spectrophotometric Determination of Fluoxetine and Sertraline in Pharmaceutical Formulations and Biological Fluid
Simultaneous spectrophotometric estimation of Fluoxetine and Sertraline in tablets were performed using UV–Vis spectroscopic and Artificial Neural Networks (ANN). Absorption spectra of two components were recorded in 200–300 nm wavelengths region with an interval of 1 nm. The calibration models were...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shaheed Beheshti University of Medical Sciences
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5603857/ https://www.ncbi.nlm.nih.gov/pubmed/28979303 |
_version_ | 1783264780317884416 |
---|---|
author | Akbari Hasanjani, Hamid Reza Sohrabi, Mahmoud Reza |
author_facet | Akbari Hasanjani, Hamid Reza Sohrabi, Mahmoud Reza |
author_sort | Akbari Hasanjani, Hamid Reza |
collection | PubMed |
description | Simultaneous spectrophotometric estimation of Fluoxetine and Sertraline in tablets were performed using UV–Vis spectroscopic and Artificial Neural Networks (ANN). Absorption spectra of two components were recorded in 200–300 nm wavelengths region with an interval of 1 nm. The calibration models were thoroughly evaluated at several concentration levels using the spectra of synthetic binary mixture (prepared using orthogonal design). Three layers feed-forward neural networks using the back-propagation algorithm (B.P) has been employed for building and testing models. Several parameters such as the number of neurons in the hidden layer, learning rate and the number of epochs were optimized. The Relative Standard Deviation (RSD) for each component in real sample was calculated as 1.06 and 1.33 for Fluoxetine and Sertraline, respectively. The results showed a very good agreement between true values and predicted concentration values. The proposed procedure is a simple, precise and convenient method for the determination of Fluoxetine and Sertraline in commercial tablets. |
format | Online Article Text |
id | pubmed-5603857 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Shaheed Beheshti University of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-56038572017-10-04 Artificial Neural Networks (ANN) for the Simultaneous Spectrophotometric Determination of Fluoxetine and Sertraline in Pharmaceutical Formulations and Biological Fluid Akbari Hasanjani, Hamid Reza Sohrabi, Mahmoud Reza Iran J Pharm Res Original Article Simultaneous spectrophotometric estimation of Fluoxetine and Sertraline in tablets were performed using UV–Vis spectroscopic and Artificial Neural Networks (ANN). Absorption spectra of two components were recorded in 200–300 nm wavelengths region with an interval of 1 nm. The calibration models were thoroughly evaluated at several concentration levels using the spectra of synthetic binary mixture (prepared using orthogonal design). Three layers feed-forward neural networks using the back-propagation algorithm (B.P) has been employed for building and testing models. Several parameters such as the number of neurons in the hidden layer, learning rate and the number of epochs were optimized. The Relative Standard Deviation (RSD) for each component in real sample was calculated as 1.06 and 1.33 for Fluoxetine and Sertraline, respectively. The results showed a very good agreement between true values and predicted concentration values. The proposed procedure is a simple, precise and convenient method for the determination of Fluoxetine and Sertraline in commercial tablets. Shaheed Beheshti University of Medical Sciences 2017 /pmc/articles/PMC5603857/ /pubmed/28979303 Text en © 2017 by School of Pharmacy Shaheed Beheshti University of Medical Sciences and Health Services This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Akbari Hasanjani, Hamid Reza Sohrabi, Mahmoud Reza Artificial Neural Networks (ANN) for the Simultaneous Spectrophotometric Determination of Fluoxetine and Sertraline in Pharmaceutical Formulations and Biological Fluid |
title | Artificial Neural Networks (ANN) for the Simultaneous Spectrophotometric Determination of Fluoxetine and Sertraline in Pharmaceutical Formulations and Biological Fluid |
title_full | Artificial Neural Networks (ANN) for the Simultaneous Spectrophotometric Determination of Fluoxetine and Sertraline in Pharmaceutical Formulations and Biological Fluid |
title_fullStr | Artificial Neural Networks (ANN) for the Simultaneous Spectrophotometric Determination of Fluoxetine and Sertraline in Pharmaceutical Formulations and Biological Fluid |
title_full_unstemmed | Artificial Neural Networks (ANN) for the Simultaneous Spectrophotometric Determination of Fluoxetine and Sertraline in Pharmaceutical Formulations and Biological Fluid |
title_short | Artificial Neural Networks (ANN) for the Simultaneous Spectrophotometric Determination of Fluoxetine and Sertraline in Pharmaceutical Formulations and Biological Fluid |
title_sort | artificial neural networks (ann) for the simultaneous spectrophotometric determination of fluoxetine and sertraline in pharmaceutical formulations and biological fluid |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5603857/ https://www.ncbi.nlm.nih.gov/pubmed/28979303 |
work_keys_str_mv | AT akbarihasanjanihamidreza artificialneuralnetworksannforthesimultaneousspectrophotometricdeterminationoffluoxetineandsertralineinpharmaceuticalformulationsandbiologicalfluid AT sohrabimahmoudreza artificialneuralnetworksannforthesimultaneousspectrophotometricdeterminationoffluoxetineandsertralineinpharmaceuticalformulationsandbiologicalfluid |